Acute Ischemic Stroke

Acute Ischemic Stroke is a medical emergency caused by a sudden blockage of blood flow to the brain, leading to oxygen deprivation. The urgency of Acute Ischemic Stroke research is paramount, given its severe impact on patients’ lives. The global burden of Acute Ischemic Stroke necessitates a concerted effort to develop interventions that can mitigate its societal and healthcare implications. 

At SCIRENT, we are dedicated to pioneering cardiovascular research to enhance scientific understanding and patient outcomes for Acute Ischemic Stroke.

Advancing Research for Improved Outcomes on Acute Ischemic Stroke

Clinical research plays a pivotal role in developing innovative treatment approaches. SCIRENT is leveraging cutting-edge methodologies to explore the evolving landscape of treatments for Acute Ischemic Stroke. Our commitment to groundbreaking discoveries aligns with the mission to improve patient outcomes and redefine the standards of care for Ischemic Stroke.

Treatment Approaches – A Multifaceted Approach

Treatment approaches for acute ischemic stroke focus on rapidly restoring blood flow to the affected part of the brain and preventing further damage. Time is of the essence in management, and early intervention is crucial to optimize outcomes. Here are key treatment approaches for AIS:

Unraveling the intricate molecular and cellular mechanisms underlying the progression of Atherosclerosis and CAD remains a challenge. Understanding how these conditions develop and evolve is crucial for developing targeted interventions.

In cases where intravenous thrombolytics are not sufficient or if the clot is large, endovascular therapy may be considered. A catheter is threaded through the blood vessels to the clot site, and a mechanical device is used to physically remove the clot.

Antiplatelet drugs, such as aspirin or clopidogrel, are often prescribed to inhibit platelet aggregation and prevent the formation of new blood clots. Aspirin is commonly administered as a prophylaxis for stroke as well as in the acute phase. Dual antiplatelet therapy may be considered in certain cases.

Maintaining optimal blood pressure is crucial in stroke management. After an acute event, blood pressure may need to be lowered gradually to reduce the risk of bleeding.

Anticoagulant medications may be used in specific cases, especially when atrial fibrillation is present. While vitamin K antagonists like warfarin were used for decades, direct oral anticoagulants are nowadays mainly used to prevent the formation of blood clots.

Supportive measures such as oxygen therapy, fluid management, and maintaining a stable body temperature are essential to support overall patient well-being after acute ischemic stroke.

Rapid identification of stroke symptoms, activation of emergency services, and prompt initiation of appropriate treatment contribute significantly to favorable outcomes of a stroke.

Research challenges

Current research in acute ischemic stroke treatment faces challenges in expanding therapeutic options beyond the hyperacute phase, with a focus on developing interventions applicable to a broader time window. Personalized medicine in stroke treatment, tailoring approaches based on individual patient characteristics, remains a complex challenge.

Addressing complications such as reperfusion injury and hemorrhagic transformation, inherent to reperfusion therapies, requires a delicate balance. Neuroprotective strategies to minimize brain damage post-stroke also present ongoing challenges, with the translational gap between preclinical findings and clinical application needing attention.

Optimizing rehabilitation strategies for long-term functional recovery and addressing health disparities in stroke care are crucial research priorities. Overcoming these challenges will significantly contribute to advancing treatment and improving patient outcomes.

Advantages of Partnering with SCIRENT

Choosing SCIRENT as a partner in Acute Ischemic Stroke research has distinct advantages. Our commitment to efficiency, data quality, and regulatory compliance sets us apart in cardiovascular research. We offer a personalized approach, tailoring research solutions to the unique needs of our clients. 

Initiating collaboration with SCIRENT is a seamless process. Contact us today to explore how our expertise can complement your research goals. Our team is ready to discuss your needs, answer queries, and embark on a collaborative journey toward groundbreaking discoveries.

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Thank you for your application.

We will get in touch shortly.